Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '25 Dec 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	327,592	187,715	116,555	154,568	113,005	78,417	Upgrade
Market Cap Growth	88.01%	61.05%	-24.59%	36.78%	44.11%	51.93%	Upgrade
Enterprise Value	327,856	187,381	117,806	156,293	110,728	76,021	Upgrade
Last Close Price	124.80	72.73	44.65	63.00	47.03	31.95	Upgrade
PS Ratio	19.15	13.50	13.14	28.18	24.02	30.64	Upgrade
PB Ratio	262.81	452.40	-108.87	-184.79	34.48	14.86	Upgrade
P/TBV Ratio	262.81	452.40	-	-	34.48	14.86	Upgrade
P/FCF Ratio	277.68	-	572.67	-	-	-	Upgrade
P/OCF Ratio	231.20	-	230.62	-	-	-	Upgrade
EV/Sales Ratio	18.87	13.48	13.28	28.50	23.54	29.70	Upgrade
EV/FCF Ratio	277.91	-	578.81	-	-	-	Upgrade
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57	Upgrade
Debt / FCF Ratio	12.53	-	63.96	-	-	-	Upgrade
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17	Upgrade
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19	Upgrade
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23	Upgrade
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47	Upgrade
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%	Upgrade
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%	Upgrade
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%	Upgrade
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%	Upgrade
Earnings Yield	0.07%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%	Upgrade
FCF Yield	0.36%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%	Upgrade
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.